Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Akan

Showing results (51-60 of 109) with videos related to

Pageof 11
Sort By:
Blood|December 15, 1990
Tumor necrosis factor alpha in human bone marrow recipientsO S Sardaş, M Beksaç, H Koç, et al.
Neuroradiology|January 1, 1993
Basal ganglia and white matter in pregnancy-induced hypertensionA Kökçü, C Ustün, O Bolat, et al.
Haematologia|September 5, 1998
Serum erythropoietin levels in patients with leukemia on cytostatic treatmentI Aydogdu, O Ilhan, M Beksac, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|June 7, 2016
Immunosuppressive Therapy-Induced Hepatotoxicity in Patients with Aplastic Anemiaİ Dilek, R İdilman, S Fenkçi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 26, 1998
The prevalence of seminal vesicle cysts in autosomal dominant polycystic kidney diseaseM Danaci, T Akpolat, M Baştemir, et al.
Bone Marrow Transplantation|April 3, 2001
Aerobic bacterial and fungal infections in peripheral blood stem cell transplantsG Aksu, M Z Ruhi, H Akan, et al.
Leukemia & Lymphoma|September 1, 1996
Lack of prognostic value of CD34 in adult AMLO Arslan, H Akan, M Beksac, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 11, 2018
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Introduction)M Fernández-Ruiz, Y Meije, O Manuel, et al.
BJU International|May 8, 1999
Histopathological changes and nitric oxide synthase activity in corpus cavernosum from rats with neurogenic erectile dysfunctionM M Basar, M Yildiz, F Söylemezoglu, et al.
International Journal of Antimicrobial Agents|November 24, 1999
Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics. Meropenem Study Group of TurkeyM Akova, H Akan, V Korten, et al.
Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
Blood|December 15, 1990
Tumor necrosis factor alpha in human bone marrow recipientsO S Sardaş, M Beksaç, H Koç, et al.
Neuroradiology|January 1, 1993
Basal ganglia and white matter in pregnancy-induced hypertensionA Kökçü, C Ustün, O Bolat, et al.
Haematologia|September 5, 1998
Serum erythropoietin levels in patients with leukemia on cytostatic treatmentI Aydogdu, O Ilhan, M Beksac, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|June 7, 2016
Immunosuppressive Therapy-Induced Hepatotoxicity in Patients with Aplastic Anemiaİ Dilek, R İdilman, S Fenkçi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 26, 1998
The prevalence of seminal vesicle cysts in autosomal dominant polycystic kidney diseaseM Danaci, T Akpolat, M Baştemir, et al.
Bone Marrow Transplantation|April 3, 2001
Aerobic bacterial and fungal infections in peripheral blood stem cell transplantsG Aksu, M Z Ruhi, H Akan, et al.
Leukemia & Lymphoma|September 1, 1996
Lack of prognostic value of CD34 in adult AMLO Arslan, H Akan, M Beksac, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 11, 2018
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Introduction)M Fernández-Ruiz, Y Meije, O Manuel, et al.
BJU International|May 8, 1999
Histopathological changes and nitric oxide synthase activity in corpus cavernosum from rats with neurogenic erectile dysfunctionM M Basar, M Yildiz, F Söylemezoglu, et al.
International Journal of Antimicrobial Agents|November 24, 1999
Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics. Meropenem Study Group of TurkeyM Akova, H Akan, V Korten, et al.
Pageof 11